Le Lézard
Classified in: Covid-19 virus
Subject: Stock Sale/Buyback

Blue Bird Announces Pricing of Secondary Public Offering


Blue Bird Corporation ("Blue Bird" or the "Company") (Nasdaq: BLBD), a leader in electric and low-emission school buses, announced today the pricing of an underwritten secondary public offering by certain stockholders of Blue Bird (the "Selling Stockholders") of 4,500,000 shares of Blue Bird's common stock, par value $0.0001 per share (the "Common Stock"), at a price to the public of $20.00 per share. The offering is expected to close on June 12, 2023, subject to the satisfaction of customary closing conditions. The offering consists entirely of secondary shares to be sold by the Selling Stockholders. The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

In addition, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions.

BofA Securities and Barclays are acting as joint lead book-running managers for the offering and as representatives of the underwriters. Jefferies, BMO Capital Markets and Piper Sandler will also act as joint book-running managers and Craig-Hallum, D.A. Davidson & Co., Roth Capital Partners and Academy Securities will act as co-managers for the proposed offering.

The offering is being made pursuant to an effective shelf registration statement (including a prospectus) filed by Blue Bird with the SEC on December 21, 2021 which became effective January 5, 2022 to which this communication relates. Before you invest, you should read the prospectus in the shelf registration statement and the documents incorporated by reference in that registration statement as well as the prospectus supplement and the documents incorporated by reference therein related to this offering. The offering will be made only by means of the prospectus and the related prospectus supplement. A copy of the prospectus and the related prospectus supplement relating to the offering may be obtained, when available, by visiting the SEC's website at www.sec.gov. Copies of the prospectus and the related prospectus supplement for the offering may also be obtained, when available, by contacting BofA Securities, Inc., Attn: Prospectus Department, NC1-022-02-25, 201 North Tryon, Charlotte, NC 28255-0001, e-mail: [email protected], telephone: 800-294-1322 or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, e-mail: [email protected], telephone: 888-603-5847.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Blue Bird Corporation

Blue Bird (NASDAQ: BLBD) is recognized as a technology leader and innovator of school buses since its founding in 1927. Blue Bird's dedicated team members design, engineer and manufacture school buses with a singular focus on safety, reliability, and durability. The Company is the market leader in low- and zero-emission school buses with more than 20,000 propane, natural gas, and electric powered buses in operation today.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations for future financial performance, business strategies or expectations for our business. Specifically, forward-looking statements include may include statements relating to:

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. The factors described above, as well as risk factors described in reports filed with the SEC by us (available at www.sec.gov), could cause our actual results to differ materially from estimates or expectations reflected in such forward-looking statements.


These press releases may also interest you

at 18:54
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/ Accretive acquisition of select assets in Southeast and Southwest...

at 17:25
Jolt Health Inc. ("JOLT" and or "the Company") is pleased to announce an arms-length agreement dated April 16, 2024 to acquire intellectual property to develop transdermal delivery technology for chloroquine and...

at 17:13
NioCorp Developments Ltd. ("NioCorp" or the "Company") announces that it has received a preliminary, non-binding indicative financing term sheet from the Export-Import Bank of the United States ("EXIM") as part of a...

at 17:00
Achieves first quarter targets, increases guidance Q1 2024 Highlights: Free Cash Flow of $102.1 million, compared to $73.1 million for Q1 2023, primarily derived from operating cash flows and net proceeds of $38.0 million related to the sale of two...

at 16:55
Medical Properties Trust, Inc. (the "Company" or "MPT") today issued the following statement in response to Steward Health Care's decision to commence an in-court restructuring process under Chapter 11 of the U.S. Bankruptcy Code. MPT has approved...

at 16:50
AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that...



News published on and distributed by: